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ABSTRACT
Dynamic regulation of cell–cell adhesion by the coordinated
formation and dissolution of E-cadherin-based adherens junctions
is crucial for tissue homeostasis. The actin-binding protein cortactin
interacts with E-cadherin and enables F-actin accumulation at
adherens junctions. Here, we were interested to study the broader
functional interactions of cortactin in adhesion complexes. In line with
literature, we demonstrate that cortactin binds to E-cadherin, and
that a posttranslational modification of cortactin, RhoA-induced
phosphorylation by protein kinase D1 (PKD1; also known as
PRKD1) at S298, impairs adherens junction assembly and supports
their dissolution. Two new S298-phosphorylation-dependent
interactions were also identified, namely, that phosphorylation of
cortactin decreases its interaction with β-catenin and the actin-binding
protein vinculin. In addition, binding of vinculin to β-catenin, as well as
linkage of vinculin to F-actin, are also significantly compromised upon
phosphorylation of cortactin. Accordingly, we found that regulation of
cell–cell adhesion by phosphorylation of cortactin downstream of
RhoA and PKD1 is vitally dependent on vinculin-mediated protein
interactions. Thus, cortactin, unexpectedly, is an important integration
node for the dynamic regulation of protein complexes during
breakdown and formation of adherens junctions.
KEY WORDS: Cortactin, Adherens junction, Vinculin, Protein
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INTRODUCTION
Epithelial cells are tightly interconnected and form two-dimensional
multicellular sheets (Takeichi, 2014). In vertebrates, cell–cell
adhesion is mediated by specialized structures: tight junctions,
adherens junctions and desmosomes (Takeichi, 2011). Adherens
junctions are present in all tissue-forming cells and constitute cell
junctions that are linked to the actin cytoskeleton at their
cytoplasmic side. They are dynamic structures that regulate cell
shape, maintain tissue integrity and translate acto-myosin-generated
forces throughout a tissue. They also play a major role in embryonic
morphogenesis, as well as the formation and homeostasis of
epithelial tissues (Schneider and Kolligs, 2015; Takeichi, 2011).
Adherens junctions are formed by the recruitment of
transmembrane cadherins, catenins and cytoskeletal adaptor
proteins. The prototype cadherin in epithelial cells is E-cadherin.
Upon homophilic interaction of its extracellular domains, the
intracellular domain of E-cadherin associates with cytoplasmic
proteins, such as catenins, that provide a link to the actin
cytoskeleton and dynamically regulate adhesion strength (Aberle
et al., 1996; Davis et al., 2003; Hartsock and Nelson, 2008; Huber
and Weis, 2001; Ireton et al., 2002; Rimm et al., 1995; Rimm and
Morrow, 1994). The juxtamembrane portion of the E-cadherin
cytoplasmic domain associates with p120-catenin (also known as
CTNND1), whereas its C-terminal part binds to β-catenin or
plakoglobin (Shibamoto et al., 1994; Takeichi et al., 1994).
β-Catenin has been suggested to interact with α-catenin, which
harbors an F-actin-binding motif (Provost and Rimm, 1999). Drees
et al. (2005a) and Yamada et al. (2005) have demonstrated that
in vitro monomeric α-catenin in a complex with E-cadherin and
β-catenin is unable to bind F-actin (Benjamin et al., 2010; Drees et al.,
2005a; Pokutta et al., 2008; Weis and Nelson, 2006; Yamada et al.,
2005). Recent data suggest that the stable binding of this complex to
F-actin in vitro requires mechanical force (Buckley et al., 2014). It is
as yet unclear how a short-lived, weak binding in the absence of force
is transformed into a force-dependent, stable interaction in vivo. Thus,
other actin-binding and putative scaffolding proteins might be part of
this dynamic process. One of these factors is the actin-binding protein
vinculin. This protein has been demonstrated to bind to α-catenin
under force, linking the adhesion complex to F-actin (Yonemura
et al., 2010). The actin-regulatory protein cortactin is also an
important part of the adhesion complex and directly binds to
E-cadherin (Helwani et al., 2004). Cortactin is required for the
E-cadherin–actin cooperation and actin accumulation that supports
the formation of adherens junctions (Helwani et al., 2004).
Our previous data have shown that cortactin is phosphorylated at
S298 by protein kinase D1 (PKD1; also known as PRKD1) and this
results in 14-3-3 protein binding (Eiseler et al., 2010). 14-3-3-
phospho-motif-binding proteins are known for their ability to
modulate protein interactions following phosphorylation of
consensus motifs (Aitken, 2006; Mackintosh, 2004). PKD
proteins have also been implicated in cell–cell adhesion, but the
precise molecular mechanisms are as yet elusive (Janssens et al.,
2009; Sundram et al., 2012). Here, we aimed to further elucidate the
role of cortactin and its posttranslational modification by PKD1
during the dynamic processes associated with the formation or
dissolution of adherens junctions.
RESULTS
Cortactin and PKD1 regulate cell–cell adhesion in a similar
manner
Previous work has described an interaction between cortactin and E-
cadherin in adherens junctions, and a role for cortactin in actin
accumulation at adherens junctions during contact zone extensionReceived 10 December 2015; Accepted 28 April 2016
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(Helwani et al., 2004; Ren et al., 2009). Our experiments therefore
aimed at investigating the role of cortactin in E-cadherin-mediated
cell–cell adhesion. To assess cortactin-dependent changes in cell–
cell adhesion, we performed hanging droplet trituration assays,
where adhesion is determined by evaluating the size and cohesion of
cell aggregates following extensive resuspension (Bardella et al.,
2004; Lorch et al., 2004). Our data showed that stable knockdown of
cortactin in Caco-2 cells visibly impaired cell–cell adhesion after
24 h (Fig. 1A). We have previously described a posttranslational
modification of cortactin by PKD1 resulting in phosphorylation of
cortactin at S298. As a consequence, 14-3-3 proteins bind to the
phosphorylated consensus motif and alter protein function (Eiseler
et al., 2010). PKD1 activity in turn is controlled by the GTPase
RhoA (Eiseler et al., 2009), which is also involved in signaling
pathways modulating adherens junctions. We therefore examined
whether PKD1 and cortactin act in a common pathway controlling
cell–cell adhesion. We performed hanging droplet trituration assays
using polyclonal stable Caco-2 cells expressing GFP-vector,
cortactin- and the non-phosphorylatable cortactin-S298A–GFP
mutant (Fig. 1B). The clusters formed in the presence of wild-
type cortactin were small and did not substantially differ from
controls, whereas S298A-cortactin mutant cells displayed markedly
bigger clusters, indicating enhanced cell–cell adhesion (Fig. 1B).
In parallel, we examined the effect of a stable short hairpin RNA
(shRNA)-mediated PKD1 depletion (Fig. 1C). Knockdown of
PKD1 also enhanced cell–cell adhesion in accordance with the
cortactin-S298A mutant phenotype. Given that binding of 14-3-3
proteins to phospho-consensus motifs is dependent on the presence
of a phosphate residue and not only on a negative charge (Ferl et al.,
2002; Mackintosh, 2004), we were not able to additionally employ
phosphorylation-mimicking mutations of cortactin in our
experiments. Cell–cell adhesion was further assessed using
constitutively active (PKD1-CA) and dominant-negative, kinase-
inactive (PKD1-KD) forms of PKD1 (Fig. S1A). Active PKD1
visibly impaired cell–cell adhesion with or without co-expression of
cortactin, whereas kinase-inactive PKD1-KD strongly enhanced
cell aggregation in accordance with the PKD1-knockout phenotype
(Fig. S1A). Actin accumulation and F-actin binding of cortactin are
important features that determine the role of cortactin at adherens
junctions (Han et al., 2014). To evaluate PKD1-mediated cell–cell
adhesion phenotypes in the context of these factors, we also
performed aggregation assays using a cortactin-W22A mutant,
Fig. 1. Cortactin and its phosphorylation by PKD1 modulate E-cadherin-mediated cell–cell adhesion. (A) Hanging droplet cell–cell adhesion assays with
Caco-2 cells following stable knockdown of cortactin (sh cortactin). Panels A′–D′ show representative images of three independent experiments, six replica
droplets per condition. 10,000 cells per 20 µl were incubated in hanging droplets for 24 h followed by trituration. Images taken at 10× magnification and
magnifications of rectangle regions of interest are shown. sh scramble, scrambled control shRNA. Scale bars: 100 µm. The western blot shows cortactin
knockdown in cell lysates. (B) Panels A′–C′ show hanging droplet assays of stable polyclonal Caco-2 cells expressing GFP, cortactin–GFPand cortactin-S298A–
GFP. Expression was analyzed by flow cytometry (histograms at the top). Assays were performed from three independent sources, six replica droplets per
condition (6000 cells per 20 µl). Representative images are shown. Scale bars: 100 µm. (C) Panels A′–D′ show hanging droplet assays with stable Caco-2 cells
following PKD1 depletion (sh PKD1). Experiments were performed as described in A with 10,000 cells per 20 µl droplet. Scale bars: 100 µm. The western blot
shows knockdown of PKD1 in cell lysates. (D) Cell adhesion assays of stable Caco-2 cells expressing GFP, cortactin–GFP and cortactin-S298A–GFP (as
characterized in B) on E-cadherin-bio-functionalized glass surfaces. 2000 cells per 20 µl droplets (two replicas per condition and three experiments) were
incubated for 2 and 4 h. Panels A′–C′ show a random area taken at 10× magnification after 2 h. Scale bars: 100 µm. The left-hand graph shows the mean±s.e.m.
number of adhered cells; the right-hand graph shows the mean±s.e.m. number of adhered cells after 4 h. *P<0.05; ns, not significant (two-tailed unpaired
Student’s t-test). Colored arrowheads mark clusters.
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abrogating Arp3 interaction, as well as a cortactin-6A mutant that
was generated to impair F-actin binding by alanine point
mutations in the actin-binding repeats 1, 4 and 6 (see Fig. S1B).
Both mutations visibly impaired cell–cell adhesion resulting
in phenotypes comparable to the PKD1-CA or PKD1-CA
with cortactin samples. Rescue experiments upon stable depletion
of cortactin and re-expression of shRNA-resistant cortactin or
cortactin-S298A constructs further indicated that wild-type
cortactin was able to rescue cell–cell adhesion in cortactin-
depleted cells. In contrast, expression of cortactin-S298A
enhanced cell–cell adhesion similar to the overexpression
phenotypes (Fig. S1C,D). Our data therefore suggest a robust
regulation of cell–cell adhesion by phosphorylation of cortactin at
S298 mediated by PKD1.
In order to quantify the extent of cell–cell adhesion for single
cells, we employed bio-functionalized glass surfaces presenting
purified extracellular E-cadherin–Fc fragments (Fig. 1D) (Drees
et al., 2005b) to measure adhesion of the stable cortactin-expressing
cell lines. Cells were seeded in droplets on these glass slides and
incubated for 2 or 4 h (Fig. 1D). We then quantified the number of
cells adhered to the surface of the droplet area. In line with hanging
droplet assays, there was no difference in the number of adherent
cells between wild-type cortactin or the control samples, whereas
the number of adherent cells significantly increased for the
cortactin-S298A mutant, corresponding to increased adhesion at
the E-cadherin-modified surface (Fig. 1D).
To identify a putative function of PKD1 during the formation or
dissolution of adherens junctions, we incubated confluent Caco-2
cells transiently expressing PKD1-CA or PKD1-KD in patches with
EGTA for 10 min and performed reformation kinetics by re-adding
Ca2+. During forced dissolution of adherens junctions by Ca2+
depletion up to the 10-min time point we were not able to identify
differences at adherens junctions, indicated by E-cadherin staining,
for the respective conditions (data not shown). Expression of active
PKD1-CA did not further enhance adherens junction breakdown on
top of EGTA treatment and expression of PKD1-KD did not
counteract forced dissolution of adherens junctions after impairment
of E-cadherin function, in line with the loss of cortactin–E-cadherin
complexes when adherens junctions are dissolved. However, during
formation of adherens junctions, presence of inactive PKD1-KD
strongly increased E-cadherin signals at adherens junctions after 20
(Fig. S1E, panels I′,J′) and 60 min (Fig. S1E, panels M′,N′),
whereas junctional E-cadherin staining was not as prominent for
PKD1-CA cells (Fig. S1E). Thus, inactive PKD1 or impaired
phosphorylation of cortactin at S298 seems to foster E-cadherin-
mediated adherens junction assembly and intercellular adhesion.
PKD1 is activated by adherens junction breakdown and
inactivated during assembly
We therefore investigated next, whether PKD1 and cortactin would
interact at adherens junctions using acceptor-photobleach
fluorescence resonance energy transfer (AB-FRET, Fig. 2A). This
method allows us to study direct protein interactions in fixed
samples. If FRET donors and acceptors reside within distances
<10 nm, non-radiative energy transfer from a donor to an acceptor
can occur, impairing donor fluorescence intensity. FRET is
quantified by measuring the increase in donor intensity upon
acceptor depletion (Fig. 2A). AB-FRET analysis indicated that
endogenous PKD1 interacted with cortactin–GFP and, vice versa,
that PKD1–GFP interacted with endogenous cortactin at Caco-2
adherens junctions. FRET studies with the adhesion-resident Afadin
protein were used as negative control (Fig. 2B; Fig. S2A). These
data suggest that PKD1 is physically able to phosphorylate cortactin
at adherens junctions. If this was indeed the case, PKD1 might be
inactivated during adherens junction assembly and activated upon
breakdown of adherens junctions. To examine the activation state of
PKD1 and its phosphorylation of cortactin during adherens junction
disassembly, we performed Ca2+-quenching experiments in Caco-2
cells. PKD1 was activated after addition of EGTA to medium as
indicated by an increase in S910 auto-phosphorylation, and PKD1
activation also resulted in corresponding phosphorylation of
cortactin at S298 (Fig. 2C). To verify PKD1 activation in
response to adherens junction dissolution, we also quantified
S910 phosphorylation after addition of E-cadherin-blocking
antibodies (DECMA-1). Again, PKD1 was significantly activated
upon dissolution of adherens junctions by DECMA treatment
(Fig. 2D,E). To assess PKD1 activation kinetics, we subsequently
performed Ca2+-quenching experiments. PKD1 was significantly
activated by addition of EGTA for 30 s (Fig. 2F,G) and re-ligation of
cell–cell adhesions significantly decreased PKD1 activity (Fig. 2G).
PKD1 auto-phosphorylation even dropped below basal levels after
5, 10 and 20 min of reformation for the displayed signal (Fig. 2F).
Thus, PKD1 activity was impaired during adherens junction
formation and enhanced when adherens junctions were dissolved.
To quantify the corresponding phosphorylation of cortactin at S298
in response to EGTA treatment, we detected anti-phospho-S298-
antibody signals at adherens junctions of Caco-2 cells. In line with
the PKD1 activation kinetics, pS298-cortactin levels at adherens
junctions significantly increased after 1 and 2 min of EGTA
stimulation. After 2 min, signals started to significantly decrease
and were almost completely lost at the 5-min time point, where
adherens junction integrity was also visibly affected by Ca2+
depletion (see arrowhead, Fig. S2B,C).
PKDs, and especially PKD1, are activated downstream of active
RhoA (Eiseler et al., 2009) (Fig. S2D,E). During ligation of
E-cadherin-based cell–cell adhesions, RhoA is inhibited by
recruitment of p190RhoGAP-A (also known as ARHGAP35)
(Noren et al., 2003; Wildenberg et al., 2006). Indeed, using a RhoA
FRET biosensor (Pertz et al., 2006), we show that RhoA activity is
regulated by dissolution and re-formation of adherens junctions:
dissolution of Caco-2 adherens junctions by EGTA activated RhoA,
whereas reformation of adherens junctions utilizing CaCl2 impaired
RhoA activity (Fig. 2H). A control for biosensor specificity during
EGTA-triggered activation of RhoA is shown is Fig. S2F utilizing
an inactive RhoA-T19N-sensor derivate.
In agreement with RhoA activation experiments, hanging-droplet
assays with inactive RhoA-T19N and p190RhoGAP-A displayed
enhanced cell aggregation, whereas the GTP-locked constitutively
active RhoA-V14 variant reduced aggregate size as compared to
controls (Fig. S2G).
To evaluate the role of p190RhoGAP-A and RhoA in the
regulation of PKD1 during disassembly and re-formation of
adherens junctions, we assessed Ca2+-quenching kinetics.
Activation of RhoA by Ca2+-quenching resulted in increased
PKD1 activity, which gradually decreased during reformation
(Fig. 2I; Fig. S2H). PKD1 activity in control conditions (silacz) was
markedly reduced after 5 min and dropped back to basal levels after
10 min of adherens junction re-ligation. In contrast, p190RhoGAP-
A depletion led to sustained activation of PKD1 during formation
of adhesion complexes after 5 and 10 min (Fig. 2I). In summary,
our data show PKD1 is a downstream target of RhoA and
p190RhoGAP-A, regulating the formation and dissolution of
adherens junctions by mediating phosphorylation of cortactin at
S298.
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Role of cortactin as a major downstream target of PKD1 in
adhesion complexes
Having established a RhoA–PKD1–cortactin pathway in adherens
junctions, we next examined the role of cortactin and its S298
modification during assembly of the extended adhesion complex.
First, we investigated whether phosphorylation of cortactin at S298
would alter its binding to E-cadherin (Helwani et al., 2004).
Utilizing AB-FRET, we demonstrate that the E-cadherin–cortactin
interaction was not significantly affected by the S298A mutant
(Fig. 3A). Cortactin has also been shown to foster Arp-complex-
Fig. 2. PKD1 is activated by adherens junction breakdown and inactivated during assembly. (A) Schematic diagram of an AB-FRET experiment.
(B) Quantitative AB-FRET analysis for the interaction of cortactin–GFP with endogenous PKD1 (clone C20 antibody) or Afadin (negative control) conjugated to
Alexa Fluor 568 [PKD1(c-20)-568 and Afadin-568, respectively] as well as for PKD1–GFP with endogenous cortactin–Alexa-Fluor-568 or endogenous cortactin–
Alexa-Fluor-488 and Afadin–Alexa-Fluor-568 (negative control) at Caco-2 adherens junctions. The graph shows the mean±s.e.m. percentage FRET (n=15 cells,
three independent experiments). *P<0.05 (two-tailed unpaired Student’s t-test). (C) Cortactin is phosphorylated at S298 after dissolution of adherens junctions
with EGTA (4 mM, 30 s in growthmedia). Immunoprecipitation (IP) of endogenous cortactin from lysates of confluent Caco-2 cells. The immunoprecipitation probe
was anti-cortactin-pS298 antibody, and the sample was reprobed with anti-cortactin antibody (H-191). One of three experiments is shown. Control lysates were
probed for PKD activity, with anti-pS910 antibody. Loading controls were actin and PKD1. (D) PKD1 is activated by dissolution of adherens junctions with the E-
cadherin blocking antibody DECMA-1 for 8 h. PKD1 activity is probed by anti-pS910 antibody in Caco-2 lysates. Loading controls were actin and PKD1. The
images on the right-hand side show representative confocal sections of cells after DECMA-treatment with reduced E-cadherin staining at adherens junctions
(arrowhead), recorded with similar settings. Scale bars: 10 μm. (E) Statistical analysis (means) of four experiments as shown in D. *P<0.05 (two-tailed paired
Student’s t-test). (F) PKD activation kinetics upon adherens junction dissolution and re-assembly in Caco-2 cells. Conditions were: untreated controls, 2 mM
EGTA for 30 s (EGTA 30″), and 2 mM EGTA for 30 s and then re-addition of growth medium for the indicated time (Re, reformation). Blot panels show PKD
activation kinetics detected by anti-PKD-pS910. One of five experiments is shown. (G) PKD activation from auto-phosphorylation blots of six experiments as
indicated in F. Results are mean±s.e.m. (n=6). *P<0.05, **P<0.01 (two-tailed paired Student’s t-test). (H) RhoA activity at adherens junctions detected using a
RhoA-FRET-biosensor (Pertz et al., 2006). Dissolution of E-cadherin dimers was mediated by adding 2.5 mM EGTA to growth medium at 60 s (T60); reformation
was mediated by adding 4 mMCaCl2 at 250 s (T250). The graph shows the combined relativemean±s.e.m. FRET/CFP fluorescence ratio of the indicated binned
time points from three experiments. *P<0.05; ***P<0.001; ****P<0.0001; ns, not significant (two-tailed unpaired Student’s t-test in respect to T29–31). Inactive
RhoA-T19N biosensor controls are shown in Fig. S3F. (I) p190RhoGAP-A andRhoA control PKD activity upon adherens junction formation and dissolution. Caco-
2 cells were transfected with control siRNA against LacZ (silacz) or siRNA against p190RhoGAP-A (sip190RhoGAP-A). After 48 h silacz and sip190RhoGAP-A,
samples were left untreated, stimulated with EGTA (2 mM for 30 s) or treated with EGTA followed by re-addition (Re) of growth medium. Left-hand side, PKD
activation kinetics detected by anti-pPKDS910 for one of six independent experiments. Verification of p190RhoGAP-A knockdown is shown in Fig. S2H. Right-
hand graph, relative mean±s.e.m. fold intensity of pPKDS910 signals in respect to controls. Blue bars, silacz control; red bars, sip190RhoGAP-A (sip190).
**P<0.01; ***P<0.001 (two-tailed paired Student’s t-test).
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driven actin accumulation at adherens junctions (Helwani et al.,
2004). We therefore investigated actin polymerization at adherens
junctions by determining actin–GFP incorporation into filaments
(Lorenz et al., 2004) utilizing FRET with phalloidin–Alexa-
Fluor-568. In line with Helwani et al. (2004), ectopic expression
of cortactin significantly increased actin polymerization and
accumulation at adherens junctions, yet results for cortactin-
S298A were not significantly different from those with wild-type
cortactin (Fig. S3A,B). An evaluation of donor and acceptor pre-
bleach intensities supported these findings, indicating a significant,
phosphorylation-independent F-actin accumulation at adherens
junctions of cortactin-transfected cells, whereas actin–GFP donor
intensities were not significantly different (Fig. S3B). Thus,
cortactin-S298-phosphorylation-dependent changes in cell–cell
adhesion are not likely the result of altered junctional actin
assembly.
We then asked whether binding of cortactin to E-cadherin would
change linkage of the extended adhesion complex, that is, β-catenin
to the E-cadherin intracellular domain. Interestingly, our AB-FRET
data suggested that formation of β-catenin–E-cadherin complexes in
the Caco-2 cortactin-knockdown cells was impaired (Fig. S3C).
Given that E-cadherin and β-catenin bind with very high affinity,
we investigated whether the number of E-cadherin–β-catenin
complexes was reduced following cortactin depletion by
additionally evaluating donor and acceptor pre-bleach intensities
(Fig. S3D): β-catenin–GFP (donor) intensities were found to be
Fig. 3. Delineation of cortactin-dependent adhesion complex interactions. (A) Interaction of cortactin and cortactin-S298Awith E-cadherin. Quantitative AB-
FRET analysis of cortactin–GFP or cortactin-S298A–GFP with E-cadherin–Alexa-Fluor-568 (E-Cadherin-568) at Caco-2 adherens junctions. Negative control,
GFP. The graph shows the mean±s.e.m. percentage FRET (n=15 cells and three independent experiments). **P<0.01; ***P<0.0001; ns, not significant (two-
tailed unpaired Student’s t-test). (B) Left-hand side, co-immunoprecipitation experiment (CoIP) of cortactin– and cortactin-S298A–FLAG expressed in confluent
HEK293T cells with endogenous β-catenin. Cortactin–FLAG was immunoprecipitated (IP) by FLAG-M2 antibody. CoIP was performed with anti-β-catenin
antibody, and reprobed with anti-cortactin antibody. Right-hand side, statistical analysis (mean±s.e.m.) of four CoIP experiments. *P<0.05 (two-tailed paired
Student’s t-test). (C) Interaction of endogenous cortactin with endogenous β-catenin following stable PKD1 depletion in HEK293T cells. Left-hand side, CoIP
experiment of cortactin with β-catenin. Immunoprecipitation was performed with anti-cortactin antibody. CoIP was performed with anti-β-catenin antibody, and
reprobed with anti-cortactin antibody. Right-hand side, statistical analysis (mean±s.e.m.) of five CoIP experiments. *P<0.05 (two-tailed paired Student’s t-test).
(D) Phosphorylation of cortactin at S298 modulates the direct interaction of cortactin with β-catenin. Quantitative AB-FRET analysis of cortactin–GFP or cortactin-
S298A–GFP with endogenous β-catenin–Alexa-Fluor-568 (beta-Catenin-568) at Caco-2 adherens junctions. The graph shows the mean±s.e.m. percentage
FRET (n=20 cells and three independent experiments). *P<0.05 (two-tailed unpaired Student’s t-test). (E) Knockdown of PKD1 modulates the interaction of
endogenous cortactin with endogenous β-catenin. Quantitative AB-FRET analysis for cortactin–Alexa-Fluor-488 (cortactin-488) with β-catenin–Alexa-Fluor-568
at adherens junctions in stable Caco-2 cells expressing scrambled shRNA (sh scramble) or shRNA against PKD1 (sh PKD1). Graph shows the mean±s.e.m.
percentage FRET (n=20 cells and three independent experiments). *P<0.05 (two-tailed unpaired Student’s t-test). Cell lines were as characterized in Fig. 1C.
(F) Pulldown experiment to show binding of purified β-catenin–GST to FLAG-tagged cortactin or cortactin-S298 expressed in HEK293T cell lysates. Negative
controls were empty beads and GST. The specificity control is pulldown of ENA-VSVG by β-catenin–GST (Fig. S3E). (G) Statistical analysis (mean±s.e.m.) of six
pulldown experiments. **P<0.01 (two-tailed paired Student’s t-test).
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similar, whereas E-cadherin intensities were significantly reduced
in the cortactin-knockdown samples, suggesting impaired complex
formation. Thus, cortactin might foster E-cadherin adhesion
complex formation, pointing to a putative molecular scaffold
function in adherens junctions.
We therefore performed immunoprecipitation studies of cortactin
and its S298A mutant to evaluate binding of endogenous β-catenin
to cortactin in confluent HEK293T cells. β-Catenin co-precipitated
with cortactin and binding was significantly enhanced when
phosphorylation at S298 was prevented (Fig. 3B). Co-
immunoprecipitation experiments of endogenous proteins upon
knockdown of PKD1 (Fig. 3C) or co-expression of PKD1-CA and
PKD1-KD (data not shown) yielded similar results. PKD1 depletion
or PKD1-KD expression significantly increased binding of β-
catenin (Fig. 3C). To test for a possible direct interaction of
cortactin–GFP with β-catenin at adherens junctions we additionally
performed FRET studies in Caco-2 cells. AB-FRET experiments
revealed a direct interaction of both proteins, and this interaction
was significantly enhanced when cortactin S298 phosphorylation
was prevented (cortactin-S298A) (Fig. 3D). The interaction of
endogenous β-catenin with cortactin was also significantly
increased upon depletion of PKD1 (Fig. 3E). To support these
findings, we performed GST-pulldown studies with bacterially
purified β-catenin–GST. These experiments demonstrated a
significantly increased interaction of cortactin-S298A–FLAG with
β-catenin–GST in respect to wild-type cortactin (Fig. 3F,G). The F-
actin-binding protein ENA-VSVG (Fig. S3E) was used as negative
control to verify a specific interaction of β-catenin–GST and
cortactin–FLAG proteins during pulldown experiments.
In summary our data suggest that phosphorylation of cortactin at
S298 by PKD1 modifies its ability to interact with β-catenin in
adhesion complexes.
Linkage of adhesion complexes to the actin cytoskeleton
E-cadherin adhesion complexes connect to the actin cytoskeleton
for efficient cell–cell adhesion. Cortactin can directly bind F-actin
(Weed et al., 2000; Wu and Parsons, 1993). Thus, cortactin could
mediate a connection of E-cadherin to F-actin (Bershadsky, 2004;
Helwani et al., 2004; Niessen et al., 2011). We therefore examined
the direct binding of cortactin and its S298A mutant to phalloidin–
Alexa-Fluor-568-labeled F-actin in adherens junctions.
Interestingly, binding of cortactin to junctional F-actin was
unaffected by the S298 phosphorylation. The classical actin-
binding α-catenin and non-actin-binding β-catenin served as
positive and negative controls, respectively (Fig. 4A). We
therefore sought to identify whether additional molecules would
act as F-actin linkers in the E-cadherin–β-catenin–cortactin
adhesion complexes. A potential cytoskeletal linker is the actin-
binding protein vinculin (Hazan et al., 1997; Peng et al., 2012).
Vinculin can interact with β-catenin and α-catenin (Peng et al.,
2010; Rimm et al., 1995; Yonemura et al., 2010). We performed co-
immunoprecipitation studies with cortactin and its S298A mutant
to evaluate binding of vinculin in HEK293T cells. Vinculin–GFP
co-precipitated with cortactin–FLAG proteins and binding was
significantly enhanced when phosphorylation at S298 was
prevented (Fig. 4B). Co-immunoprecipitation experiments of
endogenous vinculin and cortactin upon knockdown of PKD1
(Fig. 4C) or co-expression of PKD1-CA or PKD1-KD (data not
shown) also returned similar results. Binding of endogenous
vinculin to cortactin immunoprecipitates was significantly
increased by PKD1 depletion (Fig. 4C) or PKD1-KD expression.
To investigate a putative direct binding of vinculin–GFP to
cortactin–FLAG proteins, we performed a quantitative AB-FRET
analysis at Caco-2 adherens junctions (Fig. 4D). The interaction was
significantly enhanced for the cortactin-S298A mutant (Fig. 4D).
Knockdown of PKD1 likewise resulted in a significantly enhanced
interaction of endogenous vinculin and cortactin (Fig. 4E). In all
instances, donor and acceptor intensities were not significantly
different for the tested conditions, demonstrating un-biased
selection of cells during FRET studies (data not shown). To
support FRET-based protein interaction studies, we again
performed pulldown experiments utilizing His-tag-purified
vinculin. In line with FRET assays, binding of cortactin-S298A–
FLAG to vinculin–His6 beads was significantly enhanced in respect
to wild-type cortactin (Fig. 4F,G; Fig. S3F). E-cadherin–GFP was
used as a control (Fig. S3F) to verify a specific interaction of
vinculin–His6 and cortactin–FLAG proteins during pulldown
experiments.
Given that vinculin also binds to β-catenin (Peng et al., 2010), we
examined whether cortactin was required for this interaction. We
investigated the interaction of vinculin–GFP with endogenous β-
catenin at Caco-2 adherens junctions by AB-FRET in cells
expressing vector, cortactin–FLAG (dark, no dye) and cortactin-
S298A–FLAG (dark, no dye) (Fig. 5A). Expression of the cortactin-
S298A mutant significantly enhanced binding of vinculin to β-
catenin, whereas wild-type cortactin had no significant effect.
Depletion of PKD1 also significantly enhanced the interaction of
endogenous β-catenin and vinculin (Fig. 5B). Again, evaluation of
donor and acceptor intensities demonstrated un-biased selection of
cells during experiments (data not shown). Enhanced vinculin–β-
catenin interaction upon impaired cortactin-S298 phosphorylation
was also shown by co-immunoprecipitation experiments with
endogenous proteins upon co-expression of PKD1-CA and
PKD1-KD (Fig. 5C). We next investigated whether β-catenin
could bind to cortactin independently of its interaction with
vinculin. Co-immunoprecipitation studies with knockdown of
PKD1 and simultaneous knockdown of vinculin revealed that
cortactin–β-catenin complexes were still able to form in the PKD1-
knockdown samples, even if vinculin was depleted. Thus, enhanced
binding of β-catenin to cortactin is possible without the facilitation
of vinculin (Fig. S3G).
In the context of binding studies, we have additionally tested the
interaction of cortactin with p120-catenin and α-catenin, which can
bind β-catenin and vinculin (Fig. S3H). Interestingly, p120-catenin-
co-immunoprecipitation with cortactin was also enhanced upon
knockdown of PKD1 (Fig. S3H). This finding further supports the
hypothesis that the p190-RhoGAP-A–RhoA pathway controls
PKD1 activity, given that p120-catenin has been described to
recruit p190-RhoGAP-A during adhesion formation (Wildenberg
et al., 2006). By contrast, PKD1 depletion instead decreased co-
precipitation of α-catenin in cortactin immunocomplexes, verifying
the specificity of our binding studies (Fig. S3H).
To define the role of cortactin and its S298 phosphorylation in
vinculin-mediated actin linkage, we examined F-actin binding of
vinculin–GFP upon knockdown of PKD1 and following co-
expression of cortactin in respective cells (Fig. 5D). The vinculin–
GFP–F-actin interaction was significantly increased upon PKD1-
depletion, with and without co-expression of wild-type cortactin
(Fig. 5D), suggesting that cortactin–β-catenin–vinculin–F-actin
complexes at adherens junctions are significantly impaired by
cortactin S298 phosphorylation mediated by PKD1 (Fig. 5A–D).
Next, we wanted to verify complex linkage to E-cadherin.
Endogenous E-cadherin was precipitated from PKD1-depleted cells
or controls, and co-precipitated endogenous β-catenin, cortactin and
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vinculin were detected (Fig. 5E–H; Fig. S4A). Again, significantly
more β-catenin, cortactin and vinculin were found in E-cadherin
immunocomplexes upon knockdown of PKD1 (Fig. 5E–H;
Fig. S4A). Thus, phosphorylation of cortactin at S298 by PKD1
seems to impair linkage of E-cadherin–β-catenin–cortactin–
vinculin complexes to the actin cytoskeleton.
Vinculinmediates changes in cell–cell adhesion triggered by
PKD1-induced phosphorylation of cortactin
The data shown above suggest that vinculin might help to
mediate changes in cell–cell adhesion triggered by PKD1-
induced phosphorylation of cortactin. We therefore depleted
vinculin in Caco-2 cells stably expressing GFP, cortactin–GFP or
cortactin-S298A–GFP, respectively. These cells were used for
hanging-droplet cell–cell adhesion assays that were quantified
according to Ehrlich et al., 2002 (Fig. 6A,B; Fig. S4B). In line
with previous experiments, cortactin-S298A–GFP cells
expressing scrambled shRNA formed significantly larger
clusters (>50 cells, 52.2%) compared to cells expressing
cortactin–GFP (28.3%) or GFP (20%). Knockdown of vinculin
significantly reduced cell–cell adhesion in all samples, but
the S298A mutant cells were more prominently affected (only
Fig. 4. Connection of E-cadherin adhesion complexes to the actin cytoskeleton. (A) Binding of cortactin to the actin cytoskeleton at adherens junctions.
Quantitative AB-FRET analysis for cortactin–GFP or cortactin-S298A–GFP with F-actin (phalloidin–Alexa-Fluor-568; phallodin-568) at Caco-2 adherens
junctions. Negative control was β-catenin–GFP; positive control was α-catenin–GFP. The graph shows the mean±s.e.m. percentage FRET (n=20 cells and four
independent experiments). ns, not significant (two-tailed unpaired Student’s t-test). (B) Left-hand side, CoIP experiment of cortactin– and cortactin-S298A–FLAG
with vinculin–GFP expressed in HEK293T cells. Immunoprecipitation (IP) of cortactin–FLAG was achieved with FLAG-M2-antibody. CoIP was performed with
anti-GFP antibody, and reprobed with anti-cortactin antibody. Right-hand side, statistical analysis (mean±s.e.m.) of five independent CoIP experiments. *P<0.05
(two-tailed paired Student’s t-test). (C) Interaction of endogenous cortactin with endogenous vinculin following stable depletion of PKD1 in HEK293T cells. Left-
hand side, CoIP experiment of cortactin with vinculin. Immunoprecipitation was achieved with anti-cortactin antibody. CoIP was performed with anti-vinculin
antibody, and reprobed with anti-cortactin antibody. Right-hand side, statistical analysis (mean±s.e.m.) of five CoIP experiments. *P<0.05 (two-tailed paired
Student’s t-test). (D) Phosphorylation of cortactin at S298 modulates the direct interaction of cortactin with vinculin. Quantitative AB-FRET analysis for vinculin–
GFP with cortactin or cortactin-S298A bound to FLAG-M2–Alexa-Fluor-568 (-M2-568) at Caco-2 adherens junctions. The graph shows the mean±s.e.m.
percentage FRET (n=25 cells and three independent experiments). *P<0.05 (two-tailed unpaired Student’s t-test). (E) Knockdown of PKD1 modulates the
interaction of endogenous cortactin with endogenous vinculin. Quantitative AB-FRET analysis for vinculin–Alexa-Fluor-488 (vinculin-488) with cortactin–Alexa-
Fluor-568 (cortactin-568) at adherens junctions in stable Caco-2 cells expressing scrambled shRNA (sh scramble) or shRNA against PKD1 (sh PKD1). The graph
shows the mean±s.e.m. percentage FRET (n=15 cells and three independent experiments). Cell lines were as characterized in Fig. 1C. *P<0.05 (two-tailed
unpaired Student’s t-test). (F) Pulldown experiment to show binding of purified vinculin–His6 to cortactin– or cortactin-S298–FLAG in lysates from HEK293T cells.
Negative controls were empty beads and GST. The specificity control is pulldown of E-cadherin–GFP by vinculin–His6 (Fig. S3F). (G) Statistical analysis
(mean±s.e.m.) of five pulldown experiments. **P<0.01 (two-tailed paired Student’s t-test).
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2.1% of clusters had more than 50 cells, 38.2% of clusters had
between 11 and 50 cells, and 59.7% had aggregates consisting of
1–10 cells). In comparison to cortactin–GFP, the number of
single cells and small aggregates (1–10 cells) was significantly
increased from 51.6% (cortactin–GFP) to 59.7% for the cortactin-
S298A–GFP samples (Fig. 6A,B). Thus, upon knockdown of
vinculin, cortactin-S298A mutant cells almost completely lost
their ability to form large aggregates, whereas cortactin–GFP
samples in comparison formed midsize and comparatively more
larger clusters (>50 cells) (Fig. 6B; Table S1). In summary, these
data suggest that vinculin is indeed required for the dynamic
modulation of cell–cell adhesion by PKD1 and cortactin during
formation of adherens junctions.
PKD1 controls cortactin-S298-phosphorylation-dependent
protein interactions in mouse colonic epithelia
To substantiate our findings in a relevant in vivo situation, we
investigated whether the molecular interactions depending on the
phosphorylation of cortactin by PKD1 could also be demonstrated
in non-transformed colonic epithelia of mice. To this end, we
employed a transgenic mouse line with doxycycline-inducible
overexpression of wild-type PKD1. Mice were treated with
doxycycline for 30 days. Histological specimens of the intestine
were stained with an anti-PKD1 antibody to verify induction or
overexpression of PKD1 (Fig. 7A). In addition, we probed PKD
auto-phosphorylation (pS916) and activation loop phosphorylation
(pS744 and S748) in samples to demonstrate enhanced activity of
Fig. 5. Interaction of vinculin with β-catenin and complex cytoskeleton linkage. (A) Quantitative AB-FRET analysis for vinculin–GFP and endogenous
β-catenin–Alexa-Fluor-568 (beta-Catenin-568) at Caco-2 adherens junctions. Cells were additionally transfected with vector, cortactin–FLAG (dark) or cortactin-
S298A–FLAG (dark). The graph shows the mean±s.e.m. percentage FRET (n=24 cells and three independent experiments). *P<0.05; ns, not significant (two-
tailed unpaired Student’s t-test). (B) Knockdown of PKD1 modulates the interaction of endogenous vinculin with endogenous β-catenin. Quantitative AB-FRET
analysis for vinculin–Alexa-Fluor-488 (vinculin-488) with β-catenin–Alexa-Fluor-568 at adherens junctions in Caco-2 cells expressing scrambled shRNA (sh
scramble) or shRNA against PKD1 (sh PKD1). The graph shows the mean±s.e.m. percentage FRET (n=15 cells and three independent experiments). *P<0.05
(two-tailed unpaired Student’s t-test). Cell lines were as characterized in Fig. 1C. (C) Interaction of endogenous β-catenin with endogenous vinculin following
co-expression of vector, PKD1-CA and PKD1-KD in HEK293T cells. Left-hand side, CoIP experiment of β-catenin with vinculin. Immunoprecipitation (IP) was
achieved with anti-β-catenin antibody. CoIP was performed with anti-vinculin, and reprobed with anti-β-catenin antibody. Right-hand side, statistical analysis
(mean±s.e.m.) of fiveCoIP experiments. *P<0.05 (two-tailed paired Student’s t-test). (D) Phosphorylation of cortactin modulates the interaction of vinculin with the
actin cytoskeleton. Quantitative AB-FRET analysis for the interaction of vinculin–GFP with F-actin (phalloidin–Alexa-Fluor-568; phalloidin-568) at adherens
junctions in stable sh scramble and sh PKD1 Caco-2 cells or stable cells additionally transfected with cortactin–FLAG (dark). The graph shows the mean±s.e.m.
percentage FRET (n=20 cells and four independent experiments). *P<0.05; ***P<0.0001 (two-tailed unpaired Student’s t-test). (E) Linkage of adhesion
complexes with β-catenin, cortactin and vinculin to E-cadherin upon stable depletion of PKD1 in HEK293T cells. Representative CoIP experiment.
Immunoprecipitation was performed with anti-E-cadherin antibody. CoIPs was performed with anti-β-catenin, anti-cortactin or anti-vinculin antibodies, and
reprobedwith anti-E-cadherin antibody. (F–H) Statistical analysis (mean±s.e.m.) of six cortactin CoIPs (F), eight vinculin CoIPs (G) and seven β-catenin CoIPs (H).
*P<0.05; ***P<0.0001 (two-tailed paired Student’s t-test).
2423
RESEARCH ARTICLE Journal of Cell Science (2016) 129, 2416-2429 doi:10.1242/jcs.184721
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
PKD1 upon ectopic expression (Fig. S4C). A morphometric
analysis of histological specimens stained with E-cadherin,
β-catenin and DAPI indicated enhanced proliferation in crypts, as
demonstrated by a significantly increased total cell number per
crypt, crypt depth and crypt circumference in the colon of PKD1
knock-in mice, in line with previous data (Sinnett-Smith et al.,
2011) (Fig. 7B–D, Fig. S4D). The evaluation of marker proteins in
colon lysates demonstrated that E-cadherin, β-catenin and cortactin
expression levels were not visibly altered and vinculin expression
appeared slightly diminished in PKD1 knock-in (PKD-KI) samples
(Fig. S4E). In addition, histological sections were stained with
antibodies against claudin 1, E-cadherin, β-catenin, cortactin and
vinculin to evaluate putative changes in the localized expression of
adherens junction and tight junction proteins. Our quantitative data,
obtained from adherens junctions of three mice each, indicated that
claudin1, E-cadherin and β-catenin expression levels were not
altered to a significant extent in PKD1-KI mice, whereas junctional
cortactin and vinculin levels were reduced by 11.1 and 12.7%,
respectively (Fig. S4F). We also did not see significant changes in
intestinal permeability in vivo upon addition of FITC–dextran to the
drinking water of the respective mice (Fig. S4G). Nevertheless, even
though wild-type PKD1 did not seem to affect tight junctions, we
investigated putative effects on E-cadherin mediated cell–cell
adhesion in vivo.
To evaluate protein–protein interactions for cortactin and β-
catenin, as well as cortactin and vinculin, we performed an AB-
FRET analysis of colon sections (Fig. 7A). Our data verify an
interaction of cortactin with β-catenin (Fig. 7E, representative
images are shown in Fig. S4H) and of cortactin with vinculin
(Fig. 7F). The mean percentage FRET was significantly reduced in
PKD1-overexpressing mice by 57.3% for cortactin and β-catenin,
and 50.9% for cortactin and vinculin, respectively. Although, we
cannot exclude effects due to slightly reduced cortactin and vinculin
expression, changes in percentage FRET values by far exceed
reduced protein levels for cortactin and vinculin at adherens
junctions, which amount to ∼10%, and might also be attributed to
Fig. 6. Vinculin mediates changes in cell–cell adhesion triggered by PKD1-induced phosphorylation of cortactin. (A) Quantitative hanging droplet cell–
cell adhesion assay. Stable Caco-2 cells expressing GFP, cortactin–GFP and cortactin-S298A–GFP were depleted of vinculin (sh vinculin). Sh scramble,
non-specific control. Images were taken after 4 h of adhesion (10,000 cells per droplet) at 10× magnification before and after trituration. Representative
magnified images are depicted. Scales bar: 100 µm. Arrowheads mark clusters. (B) Quantitative analysis of cell–cell adhesion assays from A. The graph shows a
statistical analysis of the percentage of cluster types for 1–10, 11–50 and aggregates of >50 cells. Three assays with two images per condition were analyzed
(>1000 cells/image). *P<0.05; **P<0.01; ns, not significant (two-tailed unpaired Student’s t-test). A complete quantitative analysis is presented in Table S4.
Cortactin–GFP and cortacin-S298A–GFP transgene expression, and knockdown of vinculin is shown in Fig. S4B.
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impaired complex formation. As an indirect measure for the extent
of cell–cell adhesions, we further evaluated the interaction of
β-catenin with E-cadherin in the respective sections. The mean
percentage FRET in PKD1-KI animals was reduced by 43.3%
(Fig. 7G), suggesting significantly impaired formation of β-catenin–
E-cadherin-complexes, and compromised formation, but not a full
ablation, of cell–cell adhesion complexes in vivo.
Our data therefore identify several new protein interactions
implicated in the formation of E-cadherin-based adherens junctions
that are also detectable in non-transformed cells of colon epithelia
frommice. Our data further suggest that presence of cortactin and its
posttranslational modification by PKD1 are likely to play an
important role in epithelial cell–cell adhesion not only in vitro but
also in vivo.
DISCUSSION
Dynamic changes in cell–cell adhesion junctions are, to a large
extent, associated with the formation or dissolution of adhesive
Fig. 7. Cortactin-phosphorylation-dependent protein interactions in colon epithelia of PKD1 transgenic mice. (A) PKD1 transgenic knock-in and control
mice treated with doxycycline for 30 days. Panels A′–H′ and Q′–X′, show the immunohistochemistry of colon sections (anti-PKD1 anti-E-cadherin antibody).
Images were acquired with a confocal microscope with similar settings and are single confocal sections. Panels I′–L′ and Y′–AC′, show immunohistochemistry
with anti-cortactin and anti-β-catenin antibodies. Panels M′–P′ and AD′–AG′ show immunohistochemistry with anti-cortactin and anti-vinculin antibodies. Nuclei
are stained with DAPI. Scale bars: 10 µm. (B–D) Morphometric analysis of control and PKD1-KI mice. Immunohistochemistry was performed with DAPI, anti-β-
catenin and anti-E-cadherin antibody. Images were taken at 10× magnification with a Keyence BZ-9000 microscope (example images are shown in Fig. S4D).
Three mice each (11 crypts/mouse) were quantified (mean±s.e.m.). ***P<0.0001 (two-tailed unpaired Student’s t-test). (B) The total number of cells/crypt.
(C) Crypt depth (µm) measured from spatially calibrated images. (D) Crypt circumference (µm) measured from spatially calibrated images. (E) Expression of
PKD1 modulates the interaction of endogenous cortactin and β-catenin in colonic epithelia of mice. Quantitative AB-FRET analysis of cortactin–Alexa-Fluor-568
(cortactin-568) and β-catenin–Alexa-Fluor-647 (beta-Catenin-647) at adherens junctions of colonic epithelia. The graph shows the mean±s.e.m. percentage
FRET (n=45 cells and three mice). Representative FRET images are shown in Fig. S4H. (F) Expression of PKD1 modulates the interaction of endogenous
cortactin and vinculin in colonic epithelia. Quantitative AB-FRET analysis for the interaction of cortactin–Alexa-Fluor-568 and vinculin–Alexa-Fluor-647 (vinculin-
647) at adherens junctions of colonic epithelia. The graph shows themean±s.e.m. percentage FRET (n=45 cells and threemice). (G) Expression of PKD1 impairs
E-cadherin–β-catenin complex formation at adherens junctions of colon epithelia. Quantitative AB-FRET analysis for E-cadherin–Alexa-Fluor-568 (E-Cadherin-
568) with β-catenin–Alexa-Fluor-647 at adherens junctions of colon epithelia. The graph shows the mean±s.e.m. percentage FRET (n=45 cells and three mice).
*P<0.05; ***P<0.001 (two-tailed unpaired Student’s t-test).
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contact zones that govern morphogenetic processes during
development, wound healing or cancer metastasis (Takeichi,
2011, 2014). We here delineate a pathway that is initiated with the
ligation or dissolution of E-cadherin adhesion contacts and
transduced by the modulation of RhoA activity through
p190RhoGAP-A (Noren et al., 2003) to PKD1 (Fig. 2A–I).
PKD1 in-turn phosphorylates the adhesion-resident protein
cortactin (Eiseler et al., 2010), which alters adhesion complex
composition. A major part of this study was to elucidate how the
presence of cortactin and its phosphorylation by PKD1 alters
protein–protein interactions in the E-cadherin adhesion complex
and consequently the linkage of E-cadherin cell–cell contacts to the
actin cytoskeleton (Figs 3, 4 and 5). Cortactin has been previously
described to associate with E-cadherin (Helwani et al., 2004; Ren
et al., 2009) and p120-catenin (Boguslavsky et al., 2007). Here, we
were able to establish two new protein interactions in the E-cadherin
adhesion complex: binding of cortactin to β-catenin and vinculin.
Literature further suggests that cortactin enhances actin
polymerization and/or accumulation at adherens junctions
(Helwani et al., 2004). We were able to verify that this was indeed
the case. Although we have previously shown that cortactin affects
Arp-dependent synergistic actin polymerization at the leading edge
through its PKD1-mediated phosphorylation at S298 (Eiseler et al.,
2010), polymerization of junctional actin was independent of the
S298 phosphorylation (Fig. S3A,B). Thus, changes in junctional
actin polymerization are unlikely to be responsible for the PKD1-
controlled cell–cell adhesion phenotypes mediated through
cortactin. We rather show that cortactin acts as a molecular
scaffold that exhibits phosphorylation-dependent interactions with
β-catenin and vinculin. These interactions are significantly
enhanced when cortactin is not phosphorylated by PKD1
(Figs 3B–G and 4B–G). In addition, we demonstrate that PKD1-
dependent phosphorylation of cortactin modulates the interaction of
β-catenin with vinculin, and of vinculin with the actin cytoskeleton
(Fig. 5A–D). In both cases, non-phosphorylated cortactin strongly
supports the interaction. Complexes are also fully linked to E-
cadherin and this is enhanced upon PKD1 depletion (Fig. 5E–H).
Thus, cortactin and PKD1 play a crucial role for the integration of
vinculin-associated protein interactions in the E-cadherin adhesion
complex during formation of adherens junctions. Knockdown of
vinculin therefore strongly impairs enhanced cell–cell adhesion
conferred by the non-phosphorylatable cortactin mutant
(Fig. 6A,B). By recapitulating interactions in non-transformed
colon epithelia of mice, we add additional emphasis to our findings
(Fig. 7E–G). Previously, cortactin deficiency in mice had been
demonstrated to affect mammalian zygotic development by
modulating its association with actin filaments (Yu et al., 2010),
but a role in cell–cell adhesion in mice had not been investigated.
Different studies have attributed cortactin a role in epithelial
(Rezaee et al., 2013; Zhao et al., 2012) and endothelial barrier
functions (Dudek et al., 2004; Schnoor et al., 2011). However, wild-
type PKD1-KI mice, in line with literature (Sinnett-Smith et al.,
2011), did not display obvious physical phenotypes or alterations in
tight junction proteins, such as claudin 1 (Fig. S4F,G). Our
molecular interaction studies with E-cadherin and β-catenin
(Fig. 7G) suggest that cell–cell adhesion is significantly impaired
in PKD1-KI animals, but not completely abrogated. Thus, it is likely
that tight junctions are still able to form, and putative impairments in
barrier function were not severe enough to cause clear physiological
or histological dysfunctions under basal conditions.
In summary, our data indicate that cortactin, unexpectedly, is a
crucial molecular scaffold in the E-cadherin adhesion complex
during formation of adherens junctions, altering cell–cell adhesion
by modulating β-catenin- and vinculin-mediated protein interaction
in a manner dependent on PKD1 phosphorylation (Fig. 8).
MATERIALS AND METHODS
Cell culture, plasmids, antibodies and dye reagents
HEK293T cells (from the ATCC) were maintained in Dulbecco’s
modified Eagle’s medium [DMEM; with 10% fetal calf serum (FCS)
and penicillin-streptomycin] and transfected using PEI (Polysciences Inc.).
Caco-2 cells (from the DSMZ, German collection of microorganisms and
cell cultures) were cultivated in MEM medium (GlutaMAX, with 20%
FCS, non-essential amino acids, penicillin-streptomycin) and transfected
using Lipofectamine LTX (Invitrogen, Darmstadt, Germany) for cDNA
vectors or Oligofectamine (Invitrogen, Darmstadt, Germany) for small
interfering RNAs (siRNAs). Stable Caco-2 cells expressing GFP,
cortactin–GFP and cortactin-S298A–GFP were generated by G418
selection (6 mg/ml) for 2 months and sorted to establish polyclonal
lines. Stable Caco-2 cells with knockdown of cortactin and PKD1 or non-
specific shRNA scramble cell lines were generated by lentiviral
transduction followed by selection with puromycin (6 µg/ml) for 3
weeks. Lentiviruses were generated as described previously (Eiseler et al.,
2012). To generate stable Caco-2 cells expressing GFP, cortactin–GFP and
cortactin-S298A–GFP with shRNA scramble or vinculin shRNAs, stable
cells were transduced with respective lentiviruses and subjected to
selection with G418 and puromycin (6 mg/ml, 6 µg/ml) for 3 weeks.
All experiments with stable cell lines were conducted after 2 weeks of
growth in standard growth medium to allow for recovery from the
selection. A full list of cDNA expression plasmids, lentiviral shRNA
constructs and siRNAs is provided in Table S1. A full list of antibodies
with dilutions used in this study is available in Table S2.
Total cell lysates and co-immunoprecipitation
Total cell lysates and co-immunoprecipitation experiments (CoIPs) were
performed as described previously (Eiseler et al., 2010, 2012). CoIPs were
performed in transiently transfected or stable HEK293T cells. Following
western blot transfer, quantitative analysis was performed by measuring
integrated band density using ImageJ. Integrated density of CoIPs was
normalized to precipitated bait protein. Quantified PKD1-pS910 signals in
cell lysates were normalized to PKD1 expression. Values shown represent
fold change with respect to controls.
Protein purification and pulldown experiments
β-Catenin–GST and vinculin–His6 were expressed in BL21-bacteria and
purified as described previously (Eiseler et al., 2016). For pulldown
experiments, 20 µl of purified protein on beads was incubated for 4 h with
2 mg of total cell lysate from HEK293T cells expressing the indicated
binding partners. Pulldown assays were performed as described previously
(Eiseler et al., 2016). Empty beads and GST-conjugated protein beads were
used as negative controls.
F-actin-binding studies
F-actin cosedimentation experiments with cell lysates were performed as
described previously (Eiseler et al., 2007). For cosedimentation experiments
50 µg of 100,000 g lysate was incubated with 20 µg in vitro polymerized
F-actin (AKL-99, Cytoskeleton Inc.). Cosedimentation was assessed
following ultracentrifugation at 100,000 g for 1 h at room temperature by
loading equal amounts of supernatant and pellet fractions for SDS-PAGE
and detection on western blots.
Preparation ofmouse colon sections frommice and IHC-staining
Inducible PKD1-(Tet-ON)-mice and C57BL/6×129 control mice were
maintained in a pathogen-free environment. Mice were generated by
injecting the p2Lox targeting vector (Iacovino et al., 2011) with PKD1-
cDNA in A2lox.Cre-ES-cells and subsequent implantation in pseudo-
pregnant host animals. Mice were maintained with food and drinking water
available ad libitum. PKD1-expression was induced by the administration of
doxycycline (1 g/l and 10 g/l sucrose) to the drinking water of 12-week-old
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male mice for 30 days. Control mice were also treated with doxycycline and
animals were killed according to animal welfare regulations (state
government of Baden Wuerttemberg, proposal no: 1169). The colon was
removed, flushed with PBS, fixed and embedded in paraffin. Sections
(5 µm) were treated and stained as described previously (Armacki et al.,
2014; Wille et al., 2014). Primary antibodies were detected by Alexa-Fluor-
568- and -647-conjugated secondary antibodies; nuclei were stained with
DAPI. Confocal images sections were acquired using a Leica TCS SP8-HCS
microscope using a 40× oil immersion objective.
Intestinal permeability assay
FITC-dextran (6 mg/10 g bodyweight, Sigma-Aldrich, catalog number:
FD4) was administered to mice by oral gavage after starvation overnight. 4 h
after administration, mice were killed and serum was collected. The
concentration of FITC–dextran in the serum was determined with a
microplate reader [excitation of 485 nm, emission of 528 nm (bandpasses
were 20 nm)].
Immunofluorescence confocal microscopy and acceptor-
photobleach FRET
Immunofluorescence and AB-FRET staining was performed as described
previously (Eiseler et al., 2012). Experiments were analyzed by confocal
laser scanning microscopes LSM710 (Zeiss, Jena, Germany) and TCS SP8-
HCS (Leica, Mannheim, Germany) equipped with 40×, 63× Plan Apo oil or
water immersion objectives. Images were acquired in sequential scan mode.
Gain and offset were set in a way that all cellular structures were imaged
within the linear range of detectors having no saturated pixels and black-
level background values.
AB-FRET experiments were performed with transiently transfected or
stable Caco-2 cells, fixed, processed and stained as stated previously
(Eiseler et al., 2012; Wille et al., 2014). This method allows the
determination of protein–protein interactions indicated by an apparent
molecular proximity below 10 nm (Eiseler et al., 2012, 2016; Gu et al.,
2004; Kunkel and Newton, 2009; Oser et al., 2010; Valente et al., 2012;
Wille et al., 2014; Wouters et al., 1998; Zeug et al., 2012). The FRET
acceptor in a region of interest (ROI) was bleached by an intensive laser line
and increase in donor fluorescence, indicating FRET, was measured. AB-
FRET measurements were carried out by acquiring pre- and post-bleach
images of donor and acceptor using an automated time series. Donor dyes in
cells were either GFP-tagged proteins or Alexa-Fluor-488-labeled
antibodies. Acceptors were labeled with Alexa-Fluor-568 antibodies or
phalloidin–Alexa-Fluor-568 (F-actin). Owing to auto-fluorescence, proteins
in mouse samples were probed with Alexa-Fluor-568 (donor) and Alexa-
Fluor-647 (acceptor) antibodies. As an internal threshold, 8-bit images (256
gray values) were used for recording raw data to only register substantial
changes in fluorescence intensities as respective gray value changes. FRET
experiments were acquired from at least three independent transfections or
sources. Cells were randomly sampled from slides. In experiments with
ectopic transgenes, cells with very strong ectopic expression were not
recorded to avoid artifacts. Image analysis was performed using ImageJ.
Quantitative FRET analysis was executed by calculating the mean
Fig. 8. Regulation of cell-cell adhesion by cortactin and PKD1 during ligation of adherens junctions. Ligation of E-cadherin results in the activation of
p190RhoGAP-Awhich locally inactivates RhoA. Inactivation of RhoA impairs PKD activity and cortactin-S298 phosphorylation as well as 14-3-3β-binding (Eiseler
et al., 2010) (overview-box, left-hand side). Cortactin that is not phosphorylated at S298 substanitally enhances or stabilizes β-catenin- and vinculin-mediated
proteins interactions during adherens junction formation (overview-box, right-hand side).
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percentage FRET and s.e.m. for each cell from non-thresholded raw data for
six Sub-ROIs randomly placed on the linear adhesion junctions of Caco-2
cells within the bleached region [%FRET=((Donorpost−Donorpre)/
Donorpost)×100]. Cells that failed to show FRET in the bleach-region
were set to zero during analysis. Results are presented as scatter graphs with
single percentage FRET values. Numbers on top of graphs indicate mean
percentage FRET values and s.e.m. for all cells evaluated. Numbers in
brackets indicate the number of cells with FRET in the bleach-region. FRET
calculations from raw data sorted by the figure they are shown in are in
Table S3.
FRET-ratio-live imaging with Caco-2 cells
A RhoA-FRET-FLARE sensor (Pertz et al., 2006) was used to quantify
activation of RhoA at adherens junctions. RhoA activity was measured by
simultaneous ratio live imaging of CFP (470–500 nm) and FRET signals
(525–550 nm) using a LSM710 or Leica TCS SP8-HCS confocal
microscope (37°C, 5% CO2) with 90% open pinholes following excitation
of the donor (CFP) with a continuous 405 nm laser line at low intensities in
ROI scanning mode (LSM710) (Δ=1 s). A RhoA-T19N-FLARE sensor was
used as a negative control.
Hanging droplet cell–cell adhesion assays
Qualitative hanging droplet cell–cell adhesion assays were performed by
seeding 6000 or 10,000 transiently transfected or stable cells from three
independent sources in 20 µl droplets of growth medium on the inner lid
of a 10-cm dish (at least six replicas/condition). Hanging droplets were
incubated for 24 h on dishes filled with PBS to create a humidified
atmosphere in cell culture incubators. After 24 h, aggregates were
triturated by a 20-times re-suspension with a 10-µl pipette. Clusters
were documented at 10× magnification using a Keyence BZ-8000 bright
field microscope. Quantitative hanging droplet cell–cell adhesion assays
were performed by seeding 10,000 cells in hanging droplets. Cell
aggregates were documented at 10× magnification pre- and post-trituration
(20×10 µl) after 4 h. Post-trituration aggregates were quantified by
determining the number of aggregates and respective cell numbers, with
clusters of 1–10, 11–50 and >50 cells. Results are presented as percentage
cluster types in respect to the total cell number of images (Ehrlich et al.,
2002).
Cell–cell adhesion on E-cadherin–Fc surfaces
E-cadherin–Fc surfaces were generated and utilized to measure cell
adhesion as described previously (Drees et al., 2005b). In brief, glass
cover slips coated with streptavidin were labeled with biotin–Protein-A and
functionalized with a human E-cadherin–Fc (IgG1) fragment affinity
purified from serum-free cell culture supernatant of transfected HEK293T
cells. Cell adhesion assays with stable Caco-2 cells on E-cadherin–Fc
surfaces were performed by incubating 2000 cells in 20-µl droplets (two
replicas per condition and three slides) for 2 h and 4 h in a humidified
atmosphere in a cell culture incubator. Cover slips were washed three times
by the addition and aspiration of PBS followed by fixation with
formaldehyde and mounting onto microscopy slides. Cell adhesion to E-
cadherin–Fc surfaces was quantified by acquiring stitched images of the
entire droplet areas at 4× magnification using a Keyence BZ-9000
microscope and counting of adhered cells.
Statistical analyses
Statistical analysis was performed using Prism software version 6.00 for
Windows (GraphPad Software, San Diego, CA). Graphs depict mean±s.e.m.
for all conditions. Statistical significance is indicated by asterisks (ns, not
significant; *P<0.05 to 0.01; **P=0.01 to 0.001; ***P<0.001;
****P<0.0001).
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